[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Pages 10293-10294]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4724]



National Institutes of Health

Office of Biotechnology Activities; Office of Science Policy; 
Office of the Director; Notice of a Meeting of the NIH Blue Ribbon 

    The purpose of this notice is to inform the public about a meeting 
of the NIH Blue Ribbon Panel To Advise on the Risk Assessment of the 
National Emerging Infectious Diseases Laboratories at Boston University

[[Page 10294]]

Medical Center. The meeting will be held on Friday, March 19, 2010, at 
the National Institutes of Health, Building 31, 31 Center Drive, Floor 
6C, Room 6, Bethesda, MD 20892, from approximately 8:30 a.m. to 2 p.m.
    This meeting is the second in a series of public meetings with the 
National Research Council to review the ongoing supplementary risk 
assessment study. It was originally scheduled to take place on February 
12, 2010, but had to be postponed due to extreme weather conditions on 
the East Coast.
    Signup for public comment will begin at approximately 8 a.m. In the 
event that time does not allow for all those interested in presenting 
oral comments, anyone may file written comments using the following 
address below.
    An agenda and slides for the meeting may be obtained prior to the 
meeting by connecting to http://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For additional information concerning this meeting, 
please contact Ms. Laurie Lewallen, Advisory Committee Coordinator, 
Office of Biotechnology Activities, Office of Science Policy, Office of 
the Director, National Institutes of Health, 6705 Rockledge Drive, Room 
750, Bethesda, MD 20892-7985; telephone 301-496-9838; e-mail 
[email protected].

    Dated: March 1, 2010.
Amy P. Patterson,
Director, Office of Biotechnology Activities, National Institutes of 
[FR Doc. 2010-4724 Filed 3-4-10; 8:45 am]